Pharmacological treatment

N. Roche (Paris, France)

Source: International Congress 2017 – Latest GOLD update
Session: Latest GOLD update
Session type: Session
Number: 3179

WebcastSlide presentation

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Roche (Paris, France). Pharmacological treatment. International Congress 2017 – Latest GOLD update

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pharmacological treatments
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021


Pharmacological management
Source: Eur Respir Monogr 2016; 71: 196-217
Year: 2016


Pharmacological approach
Source: Annual Congress 2006 - The critically ill patient: chronic obstructive lung disease
Year: 2006


Pharmacological prevention of VAP
Source: Annual Congress 2003 - The diagnosis and prevention of ventilator-associated pneumonia
Year: 2003

Pharmacological and Non-pharmacological therapies that modulare lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021



Treatment of COPD: from pharmacological to instrumental therapies
Source: Eur Respir Rev 2009; 19: 7-23
Year: 2010


Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007

Pharmacological induction of A20: Anti-inflammatory effects in paediatric asthma
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019

Pharmacological treatment & current controversies in asthma
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019


Pharmacological properties of a novel PI3Kd inhibitor, DS-1515
Source: International Congress 2018 – Basic pharmacology
Year: 2018


Non-pharmacological treatment
Source: ERS Online Course 2016
Year: 2016



Non-pharmacological treatment
Source: International Congress 2017 – Latest GOLD update
Year: 2017


AZD5069: Pharmacological profile of a CXCR2 antagonist in development for the treatment of respiratory disorders
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014